Breast Cancer Information

Are Obese Women Getting Short-Changed By Chemotherapy Treatments?


How much chemotherapy does an obese woman need? Typically an obese woman with breast cancer would receive reduced doses of chemotherapy as they battle breast cancer.

Back in June of 2005, a study published in the Archives of Internal Medicine concluded that obese women should receive chemotherapy based on their actual weight, and not in reduced as amounts as it the standard practice.

And now again a study presented in the August 2005 edition of Lancet claims that doctors should not reduce chemotherapy doses for obese women when no receptors for the hormone oestrogen have been found on the breast cancer cells. This type of cancer is called oestrogen-receptor negative.

Clinicians often reduce chemotherapy doses for obese patients because of worries about how the treatment may react with the patient and affect their overall health.

According to the study's director Marco Colleoni of the European Institute of Oncology, Italy, and his colleagues, reducing the first course of chemotherapy for obese patients with oestrogen-receptor negative breast cancer proves "detrimental".

Colleoni and his team looked at the relation between body-mass index (BMI), chemotherapy dose reduction, oestrogen receptor expression, and outcome for pre-menopausal women with breast cancer by examining data from four randomized trials.

They found that 97 out of 249 obese patients received less than 85% of protocol specified dose during the first course of chemotherapy compared with patients with normal and intermediate BMI.

Obese patients with oestrogen-receptor negative disease that received 85% or more of the first protocol specified dose had significantly better disease-free survival and overall survival than those who received less than 85% of the normally recommended dosage.

Yet, obese patients with oestrogen-receptor positive breast cancer who had reduced doses of chemotherapy did not have a significant difference in their outcome compared with those given the recommended chemotherapy doses.

And contrary to popular practice, the researchers also noticed that obese patients initially treated with protocol doses of chemotherapy did not have more toxicity than patients who received reduced doses.

Dr Marco Colleoni concluded that, "Our findings suggest that for women with ER-absent or ER-low tumours, reduction in chemotherapy dose should be avoided."

The message for obese women coping with cancer is to be aware of your risks and rights. Ask your doctor will she recommend lower doses of chemotherapy for you based on your weight and ask why.

Resources: Lancet, Archives of Internal Medicine

Health author and Stanford University graduate Naweko San-Joyz lovingly writes from her home in San Diego. Her works include Acne Messages: Crack the Code of Your Zits and Say Goodbye to Acne (ISBN: 0974912204) and Skinny Fat Chicks, Why We're Still Not Getting This Dieting Thing (ISBN: 0974912212). Naweko created the Noixia philosophy to help people enhance their lives by connecting with their inner-mysteries and inner-selves. Her works take often over-looked, yet viable research and transforms in into practical tools that people can use to improve their health. Get useful, but too often ignored women's health news by visiting http://www.Noixia.com, Where Beauty Means Health.


MORE RESOURCES:

Family, faith, friendships strengthened as wife battles breast cancer
Atlanta Journal Constitution,  USA - 4 hours ago
After a whirlwind of doctors’ appointments our worst fears were confirmed: Margie was diagnosed with breast cancer. We agreed to the traditional treatment: ...
Video: 'Don't Delay Cancer Treatment' CBS
Importance of Radiation Therapy for Breast Cancer WLNS
High Tech Breast Cancer Treatment Comes to the First Coast First Coast News
all 4 news articles


UI shooting survivor dies of breast cancer
Chicago Tribune, United States - 13 hours ago
AP IOWA CITY, Iowa - Miya Rodolfo-Sioson (SEE'-o-sohn), the only survivor of a shooting rampage at the University of Iowa in 1991, has died of breast cancer ...


Susan G. Komen for the Cure(R) Announces Recipients of 2008 Komen ...
MarketWatch - 4 hours ago
Brinker Award is highest award of merit from the nation's leading breast cancer advocacy organization. DALLAS, Dec 04, 2008 /PRNewswire via COMTEX/ -- Two ...
IPA Supports Susan G. Komen Breast Cancer Foundation PR.com (press release)
all 8 news articles


European origin may up Latinas' breast cancer risk
Reuters India, India - 7 hours ago
Latina women generally have a lower risk of breast cancer compared with European, African-American or non-Latina white women do, according to the report, ...
Threat to breast cancer testing after controversial patent ruling Independent
European Ancestry May Raise Breast Cancer Risk in US Latinas Cancerpage.com
all 7 news articles


NECN

Mammogram still breast cancer screening test of choice
NECN, MA - 11 hours ago
(NECN) - People are pretty familiar with breast imaging radiology, the technology and mammograms used to detect breast cancer early, but there is some new ...


More high-risk women pre-empt breast cancer, become 'previvors'
Lex 18, KY - 11 hours ago
By the time she found the third lump, she was 25 and had watched her grandmother die of breast cancer (after being diagnosed at 55) and her mother endure ...


Health Newstrack

New Mammography Technology Effective In Detecting Breast Cancer
Science Daily (press release) - Dec 2, 2008
The ability of x-ray mammography, a standard screening tool for breast cancer, to detect lesions is reduced when performed on dense breasts, where tissue is ...
RSNA Releases Findings on New Technologies and Therapy for Breast ... DOTmed.com (press release)
New Breast Cancer Scan Cuts False Alarms WebMD
RSNA: New Techniques Improve Breast Cancer Diagnoses Breast ... Drug Topics Magazine
U.S. News & World Report - MarketWatch
all 66 news articles


HER2 may be key in treating metastatic breast cancer
Cancerfacts.com, WA - 17 hours ago
3, 2008 – Women with HER2-positive breast cancer benefit from lapatinib (TYKERB®), while women with HER2-negative breast cancer gain no incremental benefit, ...
Cardiff research finds Tamoxifen can stimulate cancer WalesOnline
all 7 news articles


Ramona teams top $111000 for breast cancer cure
Ramona Sentinel, CA - 4 hours ago
By Julie Njaa Fifty-two women representing Ramona walked 60 miles as part of the Breast Cancer 3 Day Walk benefiting Susan G. Komen for the Cure from Nov. ...


Family History of Breast Cancer Increases Risk Regardless of BRCA ...
Cancer Consultants, ID - 9 hours ago
Women with a significant family history of breast cancer but no BRCA mutation are four times more likely to develop breast cancer than women in the general ...

Breast-Cancer - Google News

home | index |site map
© 2006